REPORTING OF CARDIOVASCULAR RISK FACTORS IN LANDMARK IMMUNE CHECKPOINT INHIBITOR TRIALS

被引：0
|
作者：
Tan, Sean
Sivakumar, Seiyon
Segelov, Eva
Nicholls, Stephen J.
Nelson, Adam J.
机构：
[1] Victorian Heart Inst, Melbourne, Vic, Australia
[2] Monash Heart, Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1154-007
引用
收藏
页码：2168 / 2168
页数：1
相关论文
共 50 条
  • [31] Case Control Study Assessing Pulmonary Risk Factors for Immune Checkpoint Inhibitor Pneumonitis
    Stahlbaum, D. E.
    Jablonski, R.
    Strek, M. E.
    Reid, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [32] Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer
    Johns, Andrew C.
    Yang, Mike
    Wei, Lai
    Grogan, Madison
    Spakowicz, Daniel
    Patel, Sandipkumar H.
    Li, Mingjia
    Husain, Marium
    Kendra, Kari L.
    Otterson, Gregory A.
    Rosko, Ashley E.
    Andersen, Barbara L.
    Carbone, David P.
    Owen, Dwight H.
    Presley, Carolyn J.
    ONCOLOGIST, 2023, : E625 - E632
  • [33] Immune Checkpoint Inhibitor-Related Autoimmune Pancreatitis-Risk Factors and Outcomes
    Nuguru, Shashank
    Manne, Ashish
    GASTRO HEP ADVANCES, 2024, 3 (03): : 440 - 441
  • [34] Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
    Haddad, Tyler C.
    Zhao, Songzhu
    Li, Mingjia
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Lopez, Gabriella
    Miah, Abdul
    Wei, Lai
    Tinoco, Gabriel
    Riesenberg, Brian
    Li, Zihai
    Meara, Alexa
    Bertino, Erin M.
    Kendra, Kari
    Otterson, Gregory
    Presley, Carolyn J.
    Owen, Dwight H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1157 - 1165
  • [35] Immune checkpoint inhibitor induced hepatitis: Risk factors, outcomes, and impact on survival.
    Miah, Abdul
    Zhao, Songzhu
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Li, Mingjia
    Lopez, Gabrielle
    Haddad, Tyler
    Husain, Marium
    Kendra, Kari Lynn
    Otterson, Gregory Alan
    Wei, Lai
    Presley, Carolyn J.
    Owen, Dwight Hall
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
    Tyler C. Haddad
    Songzhu Zhao
    Mingjia Li
    Sandip H. Patel
    Andrew Johns
    Madison Grogan
    Gabriella Lopez
    Abdul Miah
    Lai Wei
    Gabriel Tinoco
    Brian Riesenberg
    Zihai Li
    Alexa Meara
    Erin M. Bertino
    Kari Kendra
    Gregory Otterson
    Carolyn J. Presley
    Dwight H. Owen
    Cancer Immunology, Immunotherapy, 2022, 71 : 1157 - 1165
  • [37] Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
    Moslehi, Javid J.
    Salem, Joe-Elie
    Sosman, Jeffrey A.
    Lebrun-Vignes, Benedicte
    Johnson, Douglas B.
    LANCET, 2018, 391 (10124): : 933 - 933
  • [38] Reporting Immune Related Adverse Events During Checkpoint Inhibitor Therapy
    Leuppi-Taegtmeyer, A.
    Wicki, A.
    Harings-Kaim, A.
    Zimmermanns, B.
    Krahenbuhl, S.
    Bravo, A. Raetz
    DRUG SAFETY, 2018, 41 (11) : 1222 - 1222
  • [39] Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
    Zhan, Mei
    Long, Qinran
    He, Jinhan
    Huang, Litao
    Wu, Bin
    Xu, Haixia
    Mo, Li
    Xu, Ting
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [40] Disparities in reporting and representation of women, older adults and racial minorities in immune checkpoint inhibitor (ICI) clinical trials.
    Bin Riaz, Irbaz
    Islam, Mahnoor
    Khan, Ahsan Masood
    Naqvi, Syed Arsalan Ahmed
    Siddiqi, Rabbia
    Hussain, Syed A.
    Singh, Parminder
    Warner, Jeremy Lyle
    Sonpavde, Guru P.
    Duma, Narjust
    Bryce, Alan Haruo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345